All Episodes

Longevity Lecture series Introduction and Lecture 1

CABINET - trial - Cabozantinib for NET

RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom

Trump is breaking media brains / NIH cuts indirect payments and scientists freak out

Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints

Why the NIH is a broken funding system

CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!

Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!

The ENTIRE healthcare system is broken, not just health insurance companies

Alcohol - Is it healthy? Everything you need to know about Beer, Wine and Spirits

2 HOUR ASH Presentation with AARON GOODMAN & MANNI & More

Systematic Reviews - An Introduction⧸ How to do them⧸ Search Strategies⧸ Common Errors

Special post-ESMO 2024 edition !

Artificial Intelligence in Medicine - My Keynote

Masking Mistakes - my panel discussion at the Emory Center for Ethics

How We Can Do Better As A County Hospital

Driver mutation lung cancer - My lecture

Post ASCO wrap up with Timothee Olivier

Critical Appraisal - My 2 hour ASCO lecture - Day 2 version

Asco Prequel - We talk about what to look for

A SM crossover - Cifu, Prasad, Mandrola

When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai

Cifu, Mandrola, Prasad - SM crossover

Patient advocates funded by Pharma

FDA makes MRD the basis for AA

Beta Blockers After Heart Attacks Don't Work

Blood based and Stool DNA colon cancer screening - Two NEJM papers

Keynote 564 - a flawed study

CONTACT-01 Cabo/ Atezo in Prostate Cancer - An Unethical trial

CAR T causes MDS??? Manni, Goodman, Raj, Prasad

Timothee and Prasad talk 2023 cancer trials

Aaron Goodman Prasad ASH UPDATES

Mandrola and Prasad

COVID19 Policy: What the US Got Wrong

Lecture 1 of 4 Curacao - How to Keep Up with Literature

Advice Pre-Med Students | Lecture at UC Berkeley

Radiation oncology in GI malignancy - Nina Sanford and Bill Hall

Hawai Keynote - Coffee and colon cancer & Censoring & More

Ethics: How IRBs Can Do Better | My Denmark Lectures (Sept 2023) 3 Of 3

Prasad's lecture gets cancelled/ Cifu Gets COVID a SM crossover

The State Of Immunotherapy In Oncology | My Denmark Lectures (Sept 2023) 2 Of 3

Do We Have Good Evidence For New Drugs? My Denmark Lectures (Sept 2023) 1 Of 3

Great And Crazy Things We Do In Medicine

Fixing Cancer Medicine w/ Timothee Olivier

Coumadin, ECMO, RCTs and more

Prasad and Mandrola discuss recent journal articles/ Republicans/ Stenting

Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover

Testosterone/ Should Scientists Debate/ Mike Joyner

Post Protocol Therapy - QOL - Adjuvant - Olivier Joins VP

ADAURA OS RESULTS - THE TRIAL WAS UNETHICAL

OBS studies vs RCTs - Trial Emulation - RCT Duplicate - We debate recent JAMA Paper

Myeloma Roundtable - Manni M. Raj C. VP discuss controversies

Mammographic Screening : A complete review of the evidence

The Crushing, Cruel Cost of Cancer Drugs - My Lecture

Sensible Med Crossover - Cifu/ Mandrola/ Prasad & Wallensky

Cochrane Mask Debates - Jefferson/ Heneghan/ Prasad

Zeb Jamrozik - Vaccine errors/ Sweden/ Equipoise & Science itself

Harvard-MIT Center for Reg. Science Lecture (4-4-23) - Dubious FDA drug Approvals

5.47 - Real World Evidence - Keynote Lecture in Denmark

5.46 - What is Science: reflections on the field

5.45 - Bar Karmma - Karmma 3 | Idacel vs 'standard care

More basics on randomized controlled trials - Part 2

RCT 101 And Papa Heme

Tom Newman And VP Discuss Public Health

5.41 - Michael Putman MCW debates me on recent policy Qs

Sensible Med Superbowl Plenary Session Crossover

5.39 - Sotorasib and Codebreak 200

Myeloma Twitter Just Makes Things Up - Lessons for All Oncologists & Expertise

5.37 - Keynote Lecture on Physician Burnout

5.36 - ASH UPDATE #4 - GEM CESAR

5.35 - ASH Update #3 - the Ascent Trial

5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed

5.33 USC Grand Rounds Hematology

5.32 - ASH Update #1 - Talquetamab NEJM

5.31 - MUST LISTEN Grand Rounds - COVID19 Updates

5.30 Rajkumar vs Goodman; Long COVID vs Long URI

5.29 Smart Start is a useless Lymphoma study

5.28 - Pandemic Amnesty or Accountability with Paul Fenyves

5.27 - Multiple Myeloma - Do Our Trials Help Patients?

5.26 - Hawaii Oncology Association Keynote Lecture

5.25 - Neurosurgery Grand Rounds by Vinay Prasad

5.24 Vlad Kogan is back to discuss Kids Test Scores

5.24 - Gerald Hsu MD PhD UCSF Heme Onc Program Director

5.23 - Subclinical Myocarditis

5.23 - ID Ethicist joins me for a 6th discussion of COVID19 policy

5.22 NordICC trial interview with PI Michael Bretthauer - Offer but don't Nudge

5.21 Science Mag Editor Condemns Ladapo But Silent About Jha

5.20 The Great Colonoscopy Debate

5.19 - NEJM's first ever RCT of Colonoscopy-- Explained

5.18 Lecture to Heme Onc Fellows - POLO; Javelin 100 bladder

5.17 - The State Of Precision Oncology

5.16 - Aaron Goodman UCSD

5.15 - How To Apply For And Get Your Perfect First Job

Unspoken Rules of Oncology - Malignant BC Part 6

Malignant Book Club - Episode 7 - famous trials

5.12 - Academics Vs Industry - A.Goodman S.Loghavi D.Steensma V.P.

5.11 - Malignant Book Club - Part 5

5.10 - Adam Cifu on clinical excellence

5.09 - Malignant Book Club Part 4

5.08 - LaceWing RCT Phase 3 Blood - Spin Cycle

5.07 - Plenary Session Alps Edition

5.06 - POLO trial now has OS results - OMG

5.05 - Citations, Metrics, Rankings in Oncology & Medicine

5.04 - Echelon 1 reports OS benefit - But does it add up?

5.03 - VPs Grand Rounds Lecture - Evidence Based Medicine - Will it Survive?

5.02 - Listener Questions - Cancer & Evidence Philosophy - What this Pod Offers

5.01 - How To Read Randomized Trials In Cancer

Lies and Exaggerations about Kids Vaccines < 5 years Old is Bad Public Health

Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer

Kids Vaccine For Under 5 years Old

H. Jack West; Lung Cancer; Podcasting; TeleHealth: PACIFIC; ADAURA;CM816: KN189

QuANTUM - Quizartinib Front Line - Ethics of Global Trials

4.67 Teclistimab for R/R Multiple Myeloma

4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??

4.65 DESTINY BREAST 04 - A complex trial to deconstruct

4.64 - DETERMINATION - Should we still use transplant Myeloma?

4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer

4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial

4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis

4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods

4.59 - How to be a better reader of case control studies

4.58 - Myeloma is a broken field - New BLOOD Paper!

4.57 - COVID19 and the Failures of Public Health w/ Leslie Bienen

4.56 - Fifth Installment of the brilliant Zeb Jamrozik

4.55 - Compilation Of Recent Covid Monologues

4.54 - Eric Collisson Professor, GI Oncologist, Physician Scientist

4.53 John Ioannidis lectures the VKPrasad Lab about COVID19

4.52 Vinay Prasad Gives a Lecture on COVID19 to a General Audience

4.51 - Vinay Prasad is Interviewed by Kristina Jenei About Academic Medicine

4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club

4.49 - Malignant Book Club Part 3 Audio

4.48 - The Truth About RCTs In Cancer Medicine

4.47 Malignant Book Club w/ Dr. Olivier Part 2 of 9

4.46 - Cancer Monologue and Lecture #5 from VP's Class on How to Appraise Medical Literature

4.45 - Malignant Book Club w/ Dr. Olivier Part 1 of 9

4.44 - Cost Of Cancer Drugs - Basics In Cancer Drug Policy

4.43 - VKPrasad Lab Update Part 2 With Timothee Olivier

4.42 - Timothee Olivier, Geneva in the first Installment of VKPrasad Lab updates

4.41 The Mask Debacle with Jacob Hale Russell

4.40 H Gilbert Welch - Melanoma Screening; Blood Based Cancer testing; Lung CA screening

4.39 Dr Zeb Jamrozik, ID ethicist, practicing doctor, great thinker

4.38 COVID-19: Boosters for Adults and Teens, Paul Offitt, Testing, Myocarditis, Campus Restrictions

4.37 MEMOIR & The Emperor Has No Clothes (a Critique of Cancer Care) with Dr. Christopher Booth

4.36 Where Are We Now with COVID-19? with Dr. John Ioannidis

4.35 Omicron, Travel Bans, Masks, Vaccine Mandates with Dr. Zeb Jamrozik

4.34 ASH Lymphoma Updates: POLARIX, ZUMA 7, BELINDA w/ Papa Heme and DRG

4.33 Melanoma: Tebentafusp, Stage Migration, Adjuvant Therapy, Training with Dr. Adil Daud

4.32 Oral Azacitidine for AML and Nelarabine for T-ALL with Dr. Bernard Marini

4.31 Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma with Dr. William Hall

4.30 COVID in Children and the US FDA Vaccine Advisory Committee with Dr. Cody Meissner

4.29 Scientific and Ethical Failures of COVID-19 with Dr. Zeb Jamrozik

4.28 Calling Out Unethical Clinical Trials, Melflufen, and Academic Oncology with Dr. Aaron Goodman

4.27 Economics and Medicine with the Host of Freakonomics, M.D., Dr. Anupam Bapu Jena

4.26 Recent Kidney Cancer Trials, Unethical Cancer Clinical Trial, & CASSIOPEIA

4.25 A Critique of COVID-19 Health Policy with Infectious Disease Ethicist Dr. Zeb Jamrozik

4.24 COVID-19: Moderna booster, Myocarditis, Progressivism, Social Media, Masks, Tests, J&J booster

4.23 Access to Cancer Medicines, Standard of Care in Oncology, and the Oncology Value Paradigm

4.22 Honoring Dr. Elilhu Estey and His Decades-Long Oncology Career

4.21 Cognitive Errors in Medical Decision-Making with Dr. Daniel Morgan & COVID-19 Policy

4.20 Vaccinating Kids and College Students, Boosters, Outdoor Masking, Bangladesh RCT, & more!

4.19 Censoring: Not on Facebook, but in Kaplan-Meier Curves

4.18 Dementia Interventions, Skills for Epidemiologists, & Aducanumab with Dr. Maria Glymour

4.17 RCTs for Cancer Drug Approval with Dr. Saroj Niraula & Myeloma Studies with Dr. Manni Mohyuddin

4.16 Treating Lymphoma, Histiocytic Disorders, Learning by Teaching, & More! with Dr. Bita Fakhri

4.15 #AllCOVID-19: the Tough Questions About Policies Concerning the Delta Variant of COVID-19

4.14 Evolution of GI Cancer Therapy, Editing JCO, Advice for Clinical Trialists with Dr. Alan Venook

4.13 Lessons from Publishing 300 Peer-Reviewed Papers & What Telemedicine Will Do to Cancer Care

4.12 Real-World Survival Outcomes for Pertuzumab and T-DM1 with Dr. Josee-Lyne Ethier

4.11 CheckMate 274, PARADIGM-HF/Ernesto, POLO, & an AI Approach to Reducing Knee Pain

4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien

4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma

4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad

4.06 CAR-T, Oncology RCTs, Social Media, Myeloma, and Career Decisions with Dr. Rahul Banerjee

4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari

4.04 Treatment Algorithm for Follicular Lymphoma & Assessing RCTs

4.03 Multiple Myeloma, Productivity Metrics, and Field Changes in Oncology with Dr. Nina Shah

4.02 The History of Breast Cancer Research and Treatment with Dr. George Sledge

4.01 Highlights from the 2021 ASCO Annual Meeting

3.90 Redesigning Health Care, Overuse, Burnout, and COVID-19 Groupthink with Dr. Marty Makary

3.89 How to Think About COVID-19 Policy with Rare Events and Declining Probabilities

3.88 Behind the Scenes for the One-Year Anniversary of Malignant with Dr. Vinay Prasad

3.87 Round Table on Multiple Myeloma Initial Therapy, High Risk, and Maintenance

3.86 Lenvatinib plus Pembrolizumab or Everolimus for Advanced RCC with Dr. Karine Tawagi

3.85 Med-Psych, Palliative Care, and Respect for Autonomy and Dignity with Dr. Joshua Briscoe

3.84 DLBCL, Bad Cancer Drugs and Bad Twitter Users with Dr. Aaron Goodman

3.83 MetaResearch, Reproducibility, Expertise, & Early Career Researchers with Dr. Ioana Cristea

3.82 Classical Hematology Chat on CVT and VITT with Drs. Sven Olson and Joseph Shatzel

3.81 Impact of COVID-19 on Sociology, Politics, and Democracy with Genève Campbell

3.80 ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) with Drs. Bishal Gyawali and Nathan Cherny

3.79 Sweden's Stance on COVID-19, Hydroxychloroquine, Schools, & Mask Data with Dr. Cathrine Axfors

3.78 Astronomy, Being a Scientist, and the Culture of the Academy with Dr. Avi Loeb

3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe

3.76 COVID-19 Transmission in Schools with Dr. Christopher Whaley and Dr. Neeraj Sood

3.75 All Things COVID-19 with Infectious Disease Professor Dr. Paul Edward Sax

3.74 Artificial Intelligence in Dermatology with Dr. Roxana Daneshjou

3.73 CheckMate 577: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

3.72 Industry Payments to US Physicians for Cancer Therapeutics with Dr. Daniel Meyers

3.71 How Research Influences Policy with Dr. Kirsten Bibbins-Domingo

3.70 The Motivation We Need to Reach the End of the COVID-19 Pandemic with Dr. Monica Gandhi

3.69 Reporting of Postprotocol Therapies in Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin

3.68 A Career in Academic Medicine & Challenges of 2021 with Former Harvard Dean, Dr. Jeffrey Flier

3.67 Thoughts on PhD Programs and Idecabtagene Vicleucel with Dr. David Russler-Germain

3.66 COVID-19 Policies and Progressing Past Disagreement with Dr. Martin Kulldorff

3.65 Banning Books, Social Media, & Medical Education with Dr. Adam Cifu

3.64 A Legal and Philosophical View on COVID-19 with Samantha Godwin

3.63 The Medical Scientist Training Program with Dr. David Russler-Germain

3.62 COVID-19 Transmission, Vaccines, & Olaparib with Dr. Tom Beer

3.61 The Neuroscience and Psychology of Recreational Drug Use in Adults with Dr. Carl Hart

3.60 Drugs for Acute Lymphoblastic Leukemia with Dr. Bernard Marini

3.59 Genetic Alterations Linked to SARS-CoV-2 Acquisition and Bad Outcomes with Dr. Nathan Pearson

3.58 Expertise and Disinformation with Jacob Hale Russell

3.57 Career Paths and Evolution of the Oncology Randomized Clinical Trial with Dr. Christopher Booth

3.56 Quality of Control Groups in RCTs of Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin

3.55 Equity in Vaccine Distribution, Cancel Culture, and Zero COVID-19 with Dr. Matthew Smith

3.54 The Passing of Dr. José Baselga

3.53 Updates on COVID-19 and Looking Back Over the Last Year with Dr. Aaron Richterman

3.52 Medicine, Leadership, SARS-CoV-2, and Social Media with Dr. Bob Wachter

3.51 COVID-19 Modeling with Youyang Gu

3.50 Evildoer Marty Makary [SHORT]

3.49 The Role of Government in Public Health and in COVID-19 Policy with Dr. Robert Freudenthal

3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris

3.47 COVID-19 Vaccine Results, Messaging on a Patient Level, & Schools with Dr. Monica Gandhi

3.46 COVID-19 Risk, Cases, and Transmission in K-12 Schools with Dr. Tracy Høeg

3.45 USMLE Steps, Residency Match, & M.D. vs D.O. with Dr. Bryan Carmody

3.44 The Role of Philosophy, COVID-19 Policy, and COVID-19 Exceptionalism with Dr. Alex John London

3.43 Reviewing the Beat AML Master Trial

3.42 Overdiagnosis and Cutaneous Melanoma Diagnoses with Dr. Adewole Adamson and Dr. Benjamin Mazer

3.41 Building a Meta-Research Career and Constructing COVID-19 Health Policy with Dr. John Ioannidis

3.40 COVID-19 Vaccines, Origin of SARS-CoV-2, and Pandemic Mitigation with Prof Francois Balloux

3.39 Public Health Messaging on COVID-19 with Drs. Julia Marcus and Stefan Baral

3.38 Oncology During COVID-19 & RCTs from Low- vs High-Income Countries with Dr. Christopher Booth

3.37 Skepticism, COVID-19, and Debating Science in the Era of Trade-Offs with Jacob Hale Russell

3.36 Sustainable Ex-Vivo Seafood with Dr. Arye Elfenbein

3.35 The Secrets of Vermont in Taming the COVID-19 Pandemic with Anne Sosin

3.34 COVID-19 From a Philosopher's Point of View with Dr. Matthew Smith

3.33 Hematologic Malignancies and Transplantation with Dr. Aaron Goodman

3.32 Publishing Original Thought in Medical Journals with Dr. Stephen Bradley

3.31 Random Thoughts on Visiting Hospital Patients During COVID-19 and Norman Wang's Lawsuit

3.30 Benefit and Risk of SpaceOAR with Dr. William Hall

3.29 Censorship in Medicine with Jonathan Darrow

3.28 Exploring the History of Medicine with Dr. Adam Rodman, host of Bedside Rounds

3.27 All Recent Acute Myeloid Leukemia Drugs with Dr. Bernard Marini

3.26 The Importance of Debate and Dialogue with Dr. Saurabh Jha

3.25 Public Health Policy on the Risk of COVID-19 in Children with Dr. Alasdair Munro

3.24 KEYNOTE-177 & Mathematic Models for Fighting COVID-19 with Dr. Wesley Pegden

3.23 Capturing Your Audience with Dr. Zubin "ZDoggMD" Damania & JAVELIN 100 with Dr. Karine Tawagi

3.22 New Podcast, Opening Schools with Dr. Vladimir Kogan, Virtual Learning with Dr. Carycruz Bueno

3.21 Affirmative Action with Leah Litman, Cost Implications with Dr. DeMartino, & Dr. John Mandrola

3.20 Public Health Messaging, COVID-19 in the U.S. Northeast, Journal Club with a Fellow

3.19 COVID-19 and the AIDS Pandemics with Dr. Monica Gandhi & Classical Hematology Chat

3.18 Social Media and News with Dr. Benjamin Mazer & Caplacizumab for TTP with Dr. Tem Bendapudi

3.17 COVID-19 and Schools in Norway with Dr. Atle Fretheim & Cancer Biology with Dr. Anthony Letai

3.16 Non-Drug Interventions with Dr. Margaret McCartney & Cancer Biology with Dr. Jason Sheltzer

3.15 COVID-19 in Children with Dr. Alasdair Munro & Pandemic Public Health with Dr. Stefan Baral

3.14 COVID-19 with Dr. John Ioannidis & Trial Eligibility with Dr. Mary-Elizabeth Percival

3.13 COVID-19 and Schools, COVID-19 and Scott Atlas, and COVID-19 Policy

3.12 TMPRSS2, Cancer Imaging with Drs. Becker and Woo, Clinical Epidemiology with Dr. Thomas Newman

3.11 Experts, Lockdown, Affirmative Action, & COVID-19 and Hearts with Professor Darrel Francis

3.10 Colon Cancer Screening, Vascepa Patent with Jonathan Darrow, PREVENTT with Dr. Toby Richards

3.09 COVID-19 Risk, Financial Toxicity, & HALT-IT for Journal Club with Fellow Dr. Justine Ryu

3.08 Racial Concordance in Birthing Mortality & HERO for Journal Club with Fellow Dr. Michael Burns

3.07 Lung Cancer Omics and Mortality, PPIs and COVID-19, & RECIST with Dr. Elizabeth Eisenhauer

3.06 COVID-19 Vaccine Access, ADAURA, QOTW, & Journal Club with Fellow Dr. Karine Tawagi

3.05 LIVE! A Midsummer Night's Stream

3.04 Listener Questions & MedTwitter and Risk-Benefit Profile of Ramucirumab with Dr. Bishal Gyawali

3.03 The National Lung Matrix Trial & the Major Flaw of the SPRINT Trial with Dr. Mark Friedberg

3.02 BONUS! National Clinician Scholars Program with Dr. Hilary Seligman

3.01 Risk of COVID-19 Among Users of PPIs, Time to Treatment Initiation, & Dr. Lynora Saxinger

2.60 BONUS! Cancer Meta-Research 101: The Lay of the Land of Cancer Research

2.59 The Best Doctor, Selinexor, & Annotation Services for NGS with Drs. Katsoulakis and Kelley

2.58 RECOVERY & Twitter, Academic Debate, and Transitioning Your Career with Dr. Andrae Vandross

2.57 RECOVERY, Clinical Trials in the US, EFS, Writing, Dr. Raj Chetty, & Dr. Ian Tannock

2.56 HER2CLIMB & Misinformation and Disinformation with Dr. Cailin O'Connor

2.55 Hydroxychloroquine for COVID-19, ASCO, QOTW, Private Equity in Medicine with Dr. Jane Zhu

2.54 Classical Hematology Chat on Thrombosis in COVID-19 & Drugs for COVID-19 with Dr. Walid Gellad

2.53 Why Agreeing 65% with Someone is Important & COVID-19 Health Policy with Dr. Daniel Morgan

2.52 Malignant Audiobook, PROfound trial, & Literature and Medicine with Dr. Adam Cifu

2.51 BONUS! Clinical Trials Part 3

2.50 Neil Ferguson, Ending Lockdown, & Updates on COVID-19 Management with Dr. Benjamin Singer

2.49 COVID-19 Contrarians, Remdesivir, & Book Club on "Malignant" with OHSU HemOnc Fellows

2.48 BONUS! Introduction to Malignant: How Bad Policy and Bad Evidence Harm People with Cancer

2.47 Remdesivir, Cloth Masks, & Incentives for COVID-19 Drug Development with Dr. Ameet Sarpatwari

2.46 Psychology Unearthed by COVID-19 Precautions & Polygenic Risk Score with Dr. Venk Murthy

2.45 Viral Spread of SARS-CoV-2, Rationing Resources, "Evidence Fiasco", & Classical Hematology Chat

2.44 ICU Management of COVID-19 with Dr. Benjamin Singer

2.43 BONUS! Novel Coronavirus and the COVID-19 Response in Oregon with Dr. John Townes

2.42 Quality-of-Life Measurement in Oncology, KnowYourTumor, & Question of the Week

2.41 BONUS! Clinical Trials Part 2: Crossover and Control Arms

2.40 BEACON part 2, NALA, & Molecular Pathology and Next-Generation Sequencing with Dr. David Carr

2.39 Effectiveness of Newer-Generation Antidepressants with Dr. Michael Hengartner

2.38 KEYNOTE-048, Academic Currency, & Trials in Low/Mid-Income Countries with Dr. Bishal Gyawali

2.37 Careerism, Presenting Abstracts, Twitter and the K-Index, & Classical Hematology Chat

2.36 Thought Leaders, NELSON, & Reliance on P Values in Cancer Trials with Dr. Sam Rubinstein

2.35 BONUS! How to Keep Up with the New Information in Medicine

2.34 Red Light, Pola for DLBCL, Hem/Onc Question of the Week, & TAILORx with Dr. Ali Khaki

2.33 Olaparib and POLO & the Classical Fallacies of Cancer Screening with Dr. H Gilbert Welch

2.32 BONUS! Clinical Trials Part 1: Thinking Better About Cancer Medicine

2.31 Listener Questions, Responsibility of Reviewers, & Duration of Response with Dr. Bishal Gyawali

2.30 Questions from a Medical Student & Epidemiology with Dr. Ellie Murray

2.29 Time from Diagnosis to Treatment in AML and Real-World Data with Dr. Sherrie Aspinall

2.28 Trastuzumab in Later Lines of Therapy for HER2+ Breast Cancer, Kaplan-Meier Curves, & Patreon

2.27 BONUS! Use of Bone-Modifying Agents Among Medicare Beneficiaries with MM with Dr. Arjun Gupta

2.26 Questions of the Week: Hematology/Oncology, USMLE Step 2 CK, & a bonus Hematology/Oncology

2.25 Questions of the Week: Hematology/Oncology, the USMLE Step 2 CK, & One From a Med Student

2.24 Questions of the Week: the USMLE Step 2 CK, Hematology/Oncology, & One From a Med Student

2.23 Question of the Week & Ethics and Inefficiencies of Clinical Trials with Dr. Jonathan Kimmelman

2.22 Question of the Week & EMR, Talking to Patients, and Being a Doctor with Dr. Robert Hirschtick

2.21 Aiming for the Hard Targets & Harm From Screening and Overdiagnosis with Dr. H Gilbert Welch

2.20 "Courageous Skeptics", Lenalidomide, QOTW, and a Political Conversation with Dr. Andy Saultz

2.19 Remembering Dr. Bernard Fisher & Self-Diagnosis with Dr. Mark Lewis

2.18 Questions of the Week, Talking About Toxicity, ASCO Guidelines Authors' COI with Dr. Eitan Amir

2.17 Questions of the Week, BEACON, & Use of Subacuate Rehab with Dr. Jonathan Yeh

2.16 FLAURA & What Truly Matters in the Career of an Academic Physician with Dr. Vinay Prasad

2.15 Bonus! The Value of Progression-Free Survival as a Treatment Endpoint with Dr. Michael Raphael

2.14 Questions of the Week & Qualifications of a Fellowship Applicant with Dr. Jeremy Cetnar

2.13 BONUS! RCTs Supporting Approvals of Cancer Drugs by EMA with Dr. Huseyin Naci

2.12 Questions of the Week, Ethics of RCTs, & Transmission and Medical Overuse with Dr. Dan Morgan

2.11 Questions of the Week, When RCTs are Necessary, & AYA Oncology with Dr. Adam Duvall

2.10 Questions of the Week: the USMLE Step 2 CK, the MKSAP, & Hematology/Oncology

2.09 Questions of the Week & Informed Consent in Clinical Trials with Dr. Lynn Jansen

2.08 Questions of the Week: the MKSAP, the USMLE Step 2 CK, & From a Med Student

2.07 Translational Research & Physical Examination Pet Peeves with Dr. Adam Cifu

2.06 Heart Failure, Choosing a Specialty, & the Bayesian Approach with Dr. Frank Harrell

2.05 Reup! Cancer Screening 101 with Dr. Adam Obley

2.04 Reup! Tumor-Treating Fields for Glioblastoma with Dr. Michael Hayes

2.03 Dr. Charles Moertel and the Modern Oncologist & Cancer Screening 101 with Dr. Adam Obley

2.02 BONUS! Improving Access to Prescription Drugs through Policy Change with Dr. Stacie Dusetzina

2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter

1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma

1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina

1.66 Employing Medical Writers & Frequentist vs Bayesian Methods with Dr. Allen Pannell

1.65 BONUS! Focusing and Building Your Presence on Twitter

1.64 Effectiveness of Cancer Screening with Dr. Joaquín Chapa and POLO with Dr. Emerson Chen

1.63 POLO, TITAN, & from ASCO: FDA Approval, Surrogate Endpoints, and Patient Experience

1.62 Rates of Cancer Screening, BILCAP Outcry, Waterfall Plots and Response Rate, & Dr. Jeff Sharman

1.61 Postpublication Metrics of RCTs, PCP Appointment Time, Bortezomib, & Dr. Christopher Booth

1.60 I-PREDICT, Flawed Phase I Trials, & the Cost of Drugs with Dr. Daniel Hartung

1.59 BONUS! Should Evidence Come with an Expiration Date? with Palmer Greene

1.58 Magic Mouthwash with Dr. Arjun Gupta & Precision Oncology with Dr. Talal Hilal

1.57 BONUS! Control Arm Quality in RCTs Leading to Anticancer Drug FDA Approval with Dr. Talal Hilal

1.56 BONUS! Real World Data & the Search for Meaningful Cancer Care with Dr. Christopher Booth

1.55 Role of a Professional Society & More with Dr. Cliff Hudis of ASCO

1.54 Association of Patient Characteristics and Tumor Genomics with Clinical Outcomes & SABR-COMET

1.53 CALGB 50303, REMoDL-B, & REMS, Orphan Drug Act, and Role of the FDA with Dr. Ameet Sarpatwari

1.52 BILCAP & DOACs for Thromboprophylaxis in Patients with Cancer with Dr. Sven Olson

1.51 BONUS! Study Time Reduction Using Surrogate End Points with Dr. Emerson Chen

1.50 Replacing RCTs, Physicians on Twitter, Open-Access, & Orthopedics with Dr. Kathryn Schabel

1.49 Student Questions, Boeing 737 Max, Pancreatic Surveillance, Leukemia Drugs with Dr. Elihu Estey

1.48 Falsified Data in Meta-Analyses and the Expert Halo Effect with Dr. Stephanie Halvorson

1.47 BONUS! Medical Reversal: Class Lecture

1.46 BONUS! Personal Finances with Dr. Tom Beer

1.45 Real-World Data, Gottlieb, & Using the EHR for Meaningful Improvement with Dr. Deborah Cohen

1.44 BONUS! Screen Time and Children's Performance

1.43 Andexanet Alfa with Dr. Tom Deloughery & National Medicaid Policy with Dr. John McConnell

1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández

1.41 Geneva Oath and Financial Relationships Among Guideline Authors with Dr. Joshua Niforatos

1.40 The World of Hematology with Dr. Thomas Deloughery

1.39 Looking Back On a Tenure in Medicine with Dr. Alex Denes

1.38 Lartruvo, New Directions for Cancer Trials, Gene Expression Profiling, & Dr. Miriam Knoll

1.37 BONUS! Medical Reversal for a General Audience

1.36 Generic Price Competition & Military Surgical Advances with Dr. Martin Schreiber

1.35 BONUS! Conflict of Interest in Oncology

1.34 Endpoints in ECOG-ACRIN 2511, Update to KEYNOTE-024, & Mentorship with Dr. Joseph Shatzel

1.33 Guarantee-Time Bias & Trials, Philanthropy, and Cancer Research with Dr. Tom Beer

1.32.1 Radiation Oncology with Dr. Brian Kavanagh

1.32 Rating Metrics, Conflict of Interest in the News, & Radiation Oncology with Dr. Brian Kavanagh

1.31 Ketogenic Diet, COMET-1 and COMET-2, the Health Insurance Marketplace with Dr. Jane Zhu

1.30 BONUS! Clinical Trial Endpoints, Drug Approval, Incentives in Oncology

1.29 RCT of Parachutes and Frameworks for Internal Medicine with Dr. Andre Mansoor

1.28 Questionable FDA Drug Approvals and Building a Career with Dr. Chadi Nabhan

1.27 BONUS! Medical Reversal

1.26 Lesson From an ASH Abstract, Behind the Scenes of a Residency Program with Dr. Sima Desai

1.25 Welch's Legacy, Interpreting NGS, Uncertainty over Pregabalin, Beyond EBM with Dr. Sam Edwards

1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate

1.23 BONUS! Developing Technology with Fewer Reversals: Maybe We Need More Translation Failure

1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner

1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees

1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross

1.19 BONUS! Introduction to Cancer Drug Policy

1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan

1.17 BONUS! Interpretation of Cancer Clinical Trials

1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong

1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare

1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing

1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu

1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology

1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali

1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet

1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints

1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds

1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola

1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority

1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity

1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser

1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross

1.02: HemOnc Fellowship and Hype in Cancer Medicine with Dr. Jeremy Cetnar

1.01: Introduction and Dr. Adam Obley